PGGM Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$78.9M Sell
910,258
-101,656
-10% -$9.74M 1.38% 28
2025
Q4
$97.2M Sell
1,011,914
-179,314
-15% -$17.4M 1.54% 28
2025
Q3
$113M Sell
1,191,228
-57,366
-5% -$5.27M 1.84% 19
2025
Q2
$109M Buy
1,248,594
+98,262
+9% +$8.33M 1.89% 19
2025
Q1
$103M Sell
1,150,332
-92,969
-7% -$8.32M 1.39% 18
2024
Q4
$99.3M Buy
1,243,301
+105,611
+9% +$9.14M 1.32% 24
2024
Q3
$102M Buy
1,137,690
+14,797
+1% +$1.24M 1.31% 24
2024
Q2
$88.4M Buy
1,122,893
+18,575
+2% +$1.52M 1.27% 22
2024
Q1
$96.2M Hold
1,104,318
1.4% 16
2023
Q4
$91M Buy
1,104,318
+94,617
+9% +$7.21M 1.38% 17
2023
Q3
$79.1M Hold
1,009,701
1.36% 17
2023
Q2
$89M Sell
1,009,701
-45,535
-4% -$3.92M 1.44% 20
2023
Q1
$85.1M Buy
1,055,236
+98,375
+10% +$8.02M 1.43% 21
2022
Q4
$74.4M Buy
956,861
+5,276
+0.6% +$428K 1.3% 24
2022
Q3
$76.8M Buy
+951,585
New +$85.5M 1.35% 21
2022
Q1
$71.8M Hold
694,032
0.36% 57
2021
Q4
$71.8M Buy
694,032
+24,369
+4% +$2.82M 0.36% 57
2021
Q3
$83.9M Sell
669,663
-8,834
-1% -$1.14M 0.43% 52
2021
Q2
$84.2M Sell
678,497
-331,235
-33% -$41.6M 0.36% 56
2021
Q1
$119M Sell
1,009,732
-106,849
-10% -$12.5M 0.52% 41
2020
Q4
$131M Sell
1,116,581
-502,559
-31% -$55.3M 0.61% 41
2020
Q3
$168M Buy
1,619,140
+139,239
+9% +$14M 0.88% 32
2020
Q2
$136M Buy
1,479,901
+7,296
+0.5% +$700K 0.79% 36
2020
Q1
$133M Buy
1,472,605
+322,836
+28% +$34.3M 0.96% 32
2019
Q4
$130M Buy
1,149,769
+612,507
+114% +$67.2M 0.74% 38
2019
Q3
$58.4M Sell
537,262
-60,000
-10% -$6.26M 0.28% 100
2019
Q2
$58.2M Buy
597,262
+42,000
+8% +$3.83M 0.29% 95
2019
Q1
$50.6M Hold
555,262
0.26% 105
2018
Q4
$50.5M Sell
555,262
-15,000
-3% -$1.4M 0.29% 89
2018
Q3
$56.1M Hold
570,262
0.3% 93
2018
Q2
$48.8M Hold
570,262
0.27% 109
2018
Q1
$45.7M Hold
570,262
0.26% 113
2017
Q4
$46M Sell
570,262
-823,091
-59% -$65.9M 0.26% 108
2017
Q3
$108M Buy
1,393,353
+53,403
+4% +$4.43M 0.53% 47
2017
Q2
$119M Sell
1,339,950
-10,266
-0.8% -$866K 0.61% 40
2017
Q1
$109M Buy
1,350,216
+896,954
+198% +$70.1M 0.56% 42
2016
Q4
$32.3M Hold
453,262
0.17% 183
2016
Q3
$39.2M Sell
453,262
-991,698
-69% -$86.4M 0.2% 138
2016
Q2
$125M Buy
1,444,960
+1,335,436
+1,219% +$108M 0.64% 39
2016
Q1
$8.21M Buy
+109,524
New +$8.25M 0.04% 312
2015
Q3
Sell
-340,243
Closed -$25.2M 379
2015
Q2
$25.2M Sell
340,243
-742,700
-69% -$56.7M 0.13% 204
2015
Q1
$84.5M Sell
1,082,943
-130,516
-11% -$9.89M 0.4% 62
2014
Q4
$87.6M Buy
1,213,459
+11,170
+0.9% +$776K 0.39% 63
2014
Q3
$74.5M Buy
1,202,289
+45,210
+4% +$2.87M 0.35% 63
2014
Q2
$73.8M Buy
1,157,079
+47,896
+4% +$2.91M 0.36% 65
2014
Q1
$68.3M Buy
1,109,183
+384,111
+53% +$22.4M 0.36% 63
2013
Q4
$41.6M Sell
725,072
-10,126
-1% -$574K 0.23% 141
2013
Q3
$39.1M Sell
735,198
-982,871
-57% -$52.9M 0.23% 147
2013
Q2
$88.4M Buy
+1,718,069
New +$84.9M 0.52% 49

Other funds holding MDT

PGGM Investments's MDT Position: Q1 2026 in Review

PGGM Investments reduced its Medtronic (MDT) stake by 10% in Q1 2026, selling an estimated $9.74M and leaving 910,258 shares worth $78.9M. The position accounts for 1.38% of the portfolio, ranked #28.

PGGM Investments first reported a position in MDT in Q2 2013 and has held it in 49 quarters since. The position peaked at $168M in Q3 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • PGGM Investments held 910,258 shares of Medtronic worth $78.9M as of Q1 2026.
  • PGGM Investments sold 101,656 Medtronic shares in Q1 2026, an estimated $9.74M.
  • Medtronic made up 1.38% of PGGM Investments's portfolio in Q1 2026, its #28 holding.
  • PGGM Investments first reported a position in Medtronic in Q2 2013 and has held it in 49 quarters since.
  • PGGM Investments's Medtronic position peaked at $168M in Q3 2020.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on PGGM Investments's 13F filing for Q1 2026, filed 15 May 2026.